LATRICIA BROADDUS: Open Payments
NPI 1003383688 · AYLETT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 10 payments from 6 companies in 2025. Trend: 2023 $93 · 2024 $229 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Qelbree, CAPLYTA, INGREZZA, Onyda XR, UZEDY, VRAYLAR.
Industry payments across VA — which companies pay providers there.
